Drug Profile
TherAmide
Latest Information Update: 28 Aug 2007
Price :
$50
*
At a glance
- Originator DOR BioPharma
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Trypanosomiasis; Viral infections
Most Recent Events
- 05 Jan 2000 No-Development-Reported for Trypanosomiasis in USA (Unknown route)
- 05 Jan 2000 No-Development-Reported for Viral infections in USA (Unknown route)
- 27 Mar 1997 New profile